N-Boc-piperazine | CAS:57260-71-6

We serve N-Boc-piperazine CAS:57260-71-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
N-Boc-piperazine

Chemical Name:  N-Boc-piperazine
CAS.NO: 57260-71-6
Synonyms:
piperazine-1-carboxylic acid tert-butyl ester
BOC-PIPERAZINE
1-Boc piperzine
t-Butyl 1-piperazincarboxylate
1,1-Dimethylethyl 1-piperazinecarboxylate
tert-butyl l-piperazinecarboxylate
tert-butyl 1-piperazinecarboxylate
1-N-BOC-PIPERAZINE

Molecular Formula: C9H18N2O2
Molecular Weight: 186.251

Physical and Chemical Properties:
Density: 1.03g/cm3
Boiling point: 258ºC at 760 mmHg
Melting point: 47-49ºC
Flash point: 109.8ºC
Refractive index: 1.467

Specification:
Appearance: White or yellowish crystal
Purity:≥99%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Refrigerator.Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Veratrazodone hydrochloride CAS:163521-08-2



Contact us for information like N-Boc-piperazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-N-BOC-PIPERAZINE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tert-butyl 1-piperazinecarboxylate Use and application,1,1-Dimethylethyl 1-piperazinecarboxylate technical grade,usp/ep/jp grade.


Related News: Any South Korean citizen returning home who has been in Hubei Province within the past two weeks will be subject to 14 days of self-quarantine and monitoring, the government said.(R)-3-(3-Fluoro-4-morpholinophenyl)-5-(hydroxymethyl)oxazolidin-2-one manufacturer As one of the world’s largest API producers and exporters, China’s chemical API production and operating income show steady growth.3-Phenoxypropyl bromide supplier Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.2-Bromo-2'-fluoroacetophenone vendor Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire.